GLUCOSE-TOLERANCE AND INSULIN RELEASE IN L-ASPARAGINASE TREATED RABBITS

被引：3
作者：
LAVINE, RL
DICINTIO, DM
机构：
来源：
METABOLISM-CLINICAL AND EXPERIMENTAL | 1980年 / 29卷 / 12期
关键词：
D O I：
10.1016/0026-0495(80)90156-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1262 / 1266
页数：5
相关论文
共 16 条
[1]   FIBRINOGEN SURVIVAL WITH [SE-75]SELENOMETHIONINE DURING L-ASPARAGINASE THERAPY [J].
BRODSKY, I ;
KAHN, SB ;
VASH, G ;
ROSS, EM ;
PETKOV, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1971, 20 (05) :477-&
[2]  
FALLETTA JM, 1972, CANCER CHEMOTH REP 1, V56, P781
[3]  
FIDLER IJ, 1972, CANCER RES, V32, P2400
[4]  
GAILANI S, 1971, CLIN PHARMACOL THER, V12, P487
[5]   TRANSIENT DIABETES-MELLITUS SECONDARY TO L-ASPARAGINASE THERAPY IN ACUTE LEUKEMIA [J].
GILLETTE, PC ;
FERNBACH, DJ ;
STARLING, KA ;
HILL, LL .
JOURNAL OF PEDIATRICS, 1972, 81 (01) :109-+
[6]  
HASKELL CM, 1969, CANCER RES, V29, P974
[7]   COATED CHARCOAL IMMUNOASSAY OF INSULIN [J].
HERBERT, V ;
LAU, KS ;
GOTTLIEB, CW ;
BLEICHER, SJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1965, 25 (10) :1375-+
[8]   DIABETOGENIC EFFECT OF L-ASPARAGINASE [J].
KHAN, A ;
ADACHI, M ;
HILL, JM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1969, 29 (10) :1373-+
[9]  
LAND VJ, 1972, CANCER, V30, P339, DOI 10.1002/1097-0142(197208)30:2<339::AID-CNCR2820300206>3.0.CO
[10]  
2-P
12